Kymera Therapeutics, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 116.70M487.18M605.90M603.13M575.76M978.03M
Current Assets
Cash & Equivalents 76.02M31.00M47.98M68.39M109.97M120.26M
Short-term Investments 15.94M265.20M394.44M338.77M264.92M368.49M
Cash & Current Investments 91.96M296.20M442.42M407.17M374.88M488.74M
Receivables - Net 0.60M15.00M
Receivables - Other 0.86M0.14M2.54M3.80M0.95M
Receivables 1.46M18.80M
Prepaid Assets 0.89M4.70M8.72M9.71M11.67M20.58M
Current Assets 92.84M302.34M451.27M419.42M405.32M510.27M
Non-Current Assets
Property, Plant & Equipment (Net) 3.79M10.84M11.88M13.33M48.13M50.46M
Long-Term Investments 162.53M125.20M152.33M61.43M362.20M
Other Non-Current Assets 1.77M1.59M6.12M6.13M5.81M5.79M
Non-Current Assets 23.86M184.84M154.63M183.72M170.44M467.77M
Liabilities
Current Liabilities
Accounts Payables 3.28M4.37M4.00M4.33M7.08M5.99M
Payables 3.28M4.37M4.00M4.33M7.08M5.99M
Accumulated Expenses 4.57M10.33M22.97M27.50M33.86M34.87M
Other Accumulated Expenses 2.62M5.82M15.17M16.98M15.10M17.80M
Current Leases 2.70M2.57M2.46M2.54M5.07M11.59M
Current Deferred Revenue 52.99M170.39M101.03M63.26M54.65M13.58M
Total Current Liabilities 34.57M110.62M92.54M71.34M85.69M67.77M
Non-Current Liabilities
Capital Leases 1.17M0.60M1.14M1.25M1.30M2.23M
Non-Current Deffered Revenue 29.64M77.84M39.30M28.00M16.77M
Preferred Stock Liabilities 59.92M
Operating Leases 16.65M14.13M13.22M12.15M77.03M72.42M
Other Non-Current Liabilities 0.10M0.07M0.25M
Total Non-Current Liabilities 203.19M146.20M112.73M
Liabilities
Total Liabilities 82.03M203.29M146.27M112.98M180.79M142.42M
Shareholder's Equity
Common Equity -74.41M283.89M459.64M490.15M394.97M835.62M
Shareholder's Equity -74.41M283.89M459.64M490.15M394.97M835.62M
Liabilities and Shareholders Equity 116.70M487.18M605.90M603.13M575.76M978.03M
Retained Earnings -76.46M-128.76M-228.98M-383.79M-530.75M-754.61M
Treasury Shares 0.23M0.11M0.04M0.28M0.59M0.75M